Today is 2019-09-21

Trial search
Filter Options
Public title Scientific title Subject ID
Registration Status Registration number Secondary ID
       More Options

20 trials have been registered

Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR1900025458

Treatment of High-Risk Acute Myeloid Leukemia With Cladribine, Cytarabine, Mitoxantrone, and Granulocyte Colony-Stimulating Factor Then Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation:single center, single arm clinical study

Department of Hematology, the Third Affiliated Hospital of Sun Yat-sen University

Observational 2019/08/26
Historical Versions ChiCTR1900023700

A randomized controlled trial for azacytidine combined with Standard induction chemotherapy regimen (daunorubicin+cytarabine) in the treatment of adult acute myeloid leukemia / high risk myelodysplastic syndrome

West China Hospital, Sichuan University

Interventional 2019/06/08
Historical Versions ChiCTR1900021059

G-CSF priming and cladribine plus cytarabine included conditioning regimen in hematopoetic transplantation of high risk or refractory acute leukemia

Xin Qiao hospital

Interventional 2019/01/27
Historical Versions ChiCTR1800020344

One-arm, two-stage clinical study for cladribine combined with G-CSF, low-dose cytarabine and peminase (C-GAP) in the treatment of relapsed refractory acute lymphoblastic leukemia/lymphocytic lymphoma

Department of Hematology, Cancer Center, Sun Yat-sen University

Observational 2018/12/25
Historical Versions ChiCTR1800017569

Clinical trial of cladribine combined with cytarabine and liposomal doxorubicin in remission induction of high-risk or refractory acute myeloid leukemia

Xinqiao Hospital

Historical Versions ChiCTR1800017310

A randomized controlled trial for arsenic trioxide combined with ESHAP (etoposide+methylprednisolone+cytarabine+cisplatin) in the treatment of relapsed or refractory ALK+ anaplastic large cell lymphoma.

Tongji Hospital Affiliated to Tongji University School of Medicine

Interventional 2018/07/23
Historical Versions ChiCTR1800015922

A randomized multicenter clinical trial of medium dose cytarabine based CEAC regimen combined with cratripine preconditioning in the treatment of high-risk NHL

The Second Affiliated Hospital of Army Medical University

Interventional 2018/04/29
Historical Versions ChiCTR1800015871

A clinical study of chidamide with FLAG (fludarabine+cytarabine+G-CSF) in the treatment of relapsed /refractory /first cycle induced non-remission acute myeloid leukemia

Anhui Provincial Hospital

Historical Versions ChiCTR1800014975

High dose cytarabine plus temozolomide for refractory/relapsed primary diffuse large B cell lymphoma of central nervous system: a prospective clinical study

North Huashan Hospital, Fudan University

Observational 2018/02/25
Historical Versions ChiCTR-INR-17012015

Evaluation of the efficacy and safety of single-dose PEG-rhG-CSF, cytarabine and aclaramycin regimens for relapse or refractory acute myeloid leukemia

Xinqiao Hospital, Chongqing

Interventional 2017/05/31
First 1 2 Next Last